Orchard Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	2017 - 2016
Revenue	21.84	22.66	1.68	2.6	2.51	2.08	Upgrade
Revenue Growth (YoY)	35.21%	1252.54%	-35.45%	3.26%	21.05%	-	Upgrade
Cost of Revenue	6.73	6.77	0.23	0.86	0.81	0.42	Upgrade
Gross Profit	15.11	15.88	1.45	1.74	1.71	1.65	Upgrade
Selling, General & Admin	44.34	49.13	54.91	64.99	57.22	31.37	Upgrade
Research & Development	72.79	93.85	86.98	93.73	117.36	205.32	Upgrade
Operating Expenses	117.12	142.97	141.88	158.72	174.58	236.69	Upgrade
Operating Income	-102.02	-127.09	-140.43	-156.98	-172.87	-235.03	Upgrade
Interest Expense / Income	3.8	3.08	2.5	2.33	1.54	0	Upgrade
Other Expense / Income	-32.75	22.87	0.83	-6.6	-8.75	-5.51	Upgrade
Pretax Income	-73.06	-153.03	-143.76	-152.71	-165.66	-229.53	Upgrade
Income Tax	-0.14	-2.37	0.83	-0.73	-2.24	0.97	Upgrade
Net Income	-72.92	-150.66	-144.58	-151.98	-163.42	-230.5	Upgrade
Shares Outstanding (Basic)	228	128	124	99	93	23	Upgrade
Shares Outstanding (Diluted)	228	128	124	99	93	23	Upgrade
Shares Change	78.24%	3.24%	24.65%	6.66%	313.31%	154.25%	Upgrade
EPS (Basic)	-4.00	-11.80	-11.70	-15.30	-17.50	-102.20	Upgrade
EPS (Diluted)	-4.00	-11.80	-11.70	-15.30	-17.50	-102.20	Upgrade
Free Cash Flow	-86.44	-74.54	-127.23	-137.07	-170.5	-101.57	Upgrade
Free Cash Flow Per Share	-3.79	-5.82	-10.26	-13.78	-18.29	-45.02	Upgrade
Gross Margin	69.17%	70.11%	86.51%	66.97%	67.97%	79.67%	Upgrade
Operating Margin	-467.13%	-560.97%	-8384.06%	-6049.25%	-6879.15%	-11321.34%	Upgrade
Profit Margin	-333.90%	-665.02%	-8631.88%	-5856.61%	-6503.06%	-11102.84%	Upgrade
Free Cash Flow Margin	-395.82%	-329.00%	-7595.76%	-5281.93%	-6784.64%	-4892.49%	Upgrade
EBITDA	-66.59	-147.21	-138.93	-148.38	-162.45	-228.33	Upgrade
EBITDA Margin	-304.93%	-649.81%	-8294.45%	-5717.84%	-6464.35%	-10998.36%	Upgrade
Depreciation & Amortization	2.67	2.74	2.33	2	1.68	1.2	Upgrade
EBIT	-69.26	-149.96	-141.26	-150.38	-164.12	-229.53	Upgrade
EBIT Margin	-317.16%	-661.91%	-8433.37%	-5795.07%	-6531.00%	-11056.12%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).